Multi-cancer early detection tests
The company develops tests for multi-cancer early detection.
Source: LinkedIn company description · Retrieved October 13, 2026
Proteotype develops multi-cancer early detection and personalised medicine tests.
Its tests measure the host response to tumour development.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops tests for multi-cancer early detection.
Source: LinkedIn company description · Retrieved October 13, 2026
The company develops personalised medicine tests.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026 and September 19, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.